经肝动脉介入治疗肝癌并发症分析

目的 探讨肝癌介入治疗并发症以及对疗效的影响。方法 回顾性分析75例经介入治疗的肝癌患者资料。对其并发症的发生率，以及预防、处理进行讨论。结果 穿刺、插管并发症发生率13％，灌注化疗后综合症发生率89％，栓塞后综合症发生率97％，胃肠粘膜损害发生率7．7％，肝功能损害发生率81％，急性肝衰竭死亡发生率8％。1例肝癌破裂死亡，发生率1．3％。结论 介入治疗是中晚期肝癌的最佳姑息治疗手段，防止或减少并发症是提高其疗效重要的一环。

Analysis of Complications in Patients with Hepatocellular Carcinoma Receiving Transarterial Interventioanl Therapy

Objective To analyze the complications in the patients with hepatocellular carcinoma(HCC)and the influence on clinical effects.Methods The clinical data of cases of HCC receiving interventional therapy were studied retrospectively,the morbidity of complications,methods of prevention and treatment were discussed.Results The incidence of vessel puncture complications was 13%;the incidence of postinfusion chemotherapy syndrome,postembolization syndrome and damage of gastroenteric mucosa was 89%,97% and 7.7% respectively.Liver dysfunction and acute liver failure was found.Once case(1.3%) died of massive reupture. Conclusion Interventional therapy is the most effctive palliative treatment for intermediate or advanced HCC.In order to improve the effects,it is important to prevent or decrease the incidence of complications.